InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
86.37
(
-0.63%
)
Bitcoin
58,384.39
(
-2.96%
)
Post# of 64738
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Paulness

Send PM Follow Ignore
Followers 94
Posts 11244
Boards Moderated 0
Alias Born 11/02/2003

Paulness

Re: lawrenceolivier post# 9144

Wednesday, 07/07/2004 10:26:37 AM

Wednesday, July 07, 2004 10:26:37 AM

Post# of 64738
LO read from the Dutton report how CYGX is unique compared to RNA.We have a DNA delivery system.




Because CytoGenix's technology controls gene expression from inside the cell, we believe the Company may be capable of developing therapeutic products that circumvent these problems. We also believe that CytoGenix is a technology leader among the handful of companies developing therapeutics around ODN technology.

This is The second have of the Dutton report that you have
over looked.And you seem to have basher vision .


Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up